Amicus Therapeutics, Inc. (FOLD)
14.34
-0.01
(-0.07%)
USD |
NASDAQ |
Feb 20, 16:00
14.34
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics SG&A Expense (Quarterly) : 117.08M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 268.40M |
| CorMedix, Inc. | 36.64M |
| Krystal Biotech, Inc. | 0.00 |
| MannKind Corp. | 58.18M |
| Keros Therapeutics, Inc. | 10.13M |